Recent research highlights the potential of a healthy gut microbiome in enhancing cancer treatment outcomes. Dr. Marcel van den Brink, a specialist in bloodborne cancers, has been at the forefront of this exploration. His work at the City of Hope Cancer Center in California underscores the importance of the gut microbiome, especially in immunotherapy, which uses the body’s immune system to fight cancer.
Microbiome and Immunotherapy
Immunotherapy relies on medications that help the immune system better attack cancer cells. The gut microbiome, a collection of microorganisms in our digestive system, appears critical in this process. A recent symposium at the City of Hope Cancer Center, attended by US Health and Human Services Secretary Robert F. Kennedy Jr., emphasized the microbiome as a ‘next frontier’ in cancer care.
One promising study involves the use of probiotics, specifically the CBM588 strain of Clostridium butyricum, in treating kidney cancer. This strain is already a popular dietary supplement in Japan for gastrointestinal health. The study, funded by the National Cancer Institute, aims to test the effectiveness of CBM588 in nearly 700 patients with advanced renal cell carcinoma.
Antibiotic Stewardship
Researchers are also focusing on antibiotic use, which can disrupt the gut microbiome. Dr. Sumanta Pal of the City of Hope Cancer Center notes that excessive antibiotic use can lead to poor cancer treatment outcomes. Many cancer centers now adopt a cautious approach, prescribing antibiotics only when necessary to avoid wiping out beneficial gut bacteria.
Dr. Arielle Elkrief from the Montreal Cancer Institute highlights the importance of ‘first, do no harm’ in antibiotic use. Her center has seen a significant reduction in antibiotic prescriptions for lung cancer patients, aligning with the broader trend of antibiotic stewardship in cancer care.
Future Directions
The role of diet, particularly fiber intake, is another area of interest. A study from the University of Texas MD Anderson Cancer Center found that a high-fiber diet improved treatment responses in melanoma patients. This connection between diet and gut bacteria is a promising avenue for future research.
As the understanding of the gut microbiome’s role in cancer treatment grows, researchers like Dr. van den Brink continue to explore its potential. The hope is that these insights will lead to more effective and personalized cancer therapies, ultimately improving patient outcomes.
Original reporting: KTVZ (Central Oregon) — read the source article.
